Vivo Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 43

Professionals

  • Investments
  • 292

  • Portfolio
  • 61

  • Exits
  • 180

Exits

Vivo Capital General Information

Company Description

Founded in 1996, Vivo Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest in biopharmaceuticals, specialty pharmaceuticals, medical devices, and other subsectors of healthcare and life sciences sectors based in the United States & East Asian region.

Business Details

Formerly Known As
BioAsia Investments
Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Corporate Office
  • 192 Lytton Avenue
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Vivo Capital Investments (292)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ajax Therapeutics 13-May-2024 Later Stage VC 0000 Drug Discovery Generating Revenue
Unicycive 13-May-2024 0000 0000 Drug Discovery Generating Revenue/Not Profitable 000000 00000000 00
Zenas BioPharma 07-May-2024 00000 00000 00000 Drug Discovery Clinical Trials - Phase 3
Clasp Therapeutics 20-Mar-2024 00000 00000 00000 Biotechnology Generating Revenue 0000 0000000
Regulus Therapeutics 14-Mar-2024 0000 00000 Drug Discovery Generating Revenue
BlossomHill Therapeutics 29-Feb-2024 00000 00000 00000 Drug Discovery Product Development 0000000 000000 00
Silence Therapeutics 13-Feb-2024 0000 00000 Drug Discovery Generating Revenue/Not Profitable
Adverum Biotechnologies 08-Feb-2024 0000 00000 Biotechnology Generating Revenue/Not Profitable
Attralus 26-Jan-2024 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
Neocis 10-Jan-2024 Later Stage VC 0000 Surgical Devices Generating Revenue
You’re viewing 10 of 292 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivo Capital Exits (180)

Company Name Exit Date Exit Type Exit Size
Tarsus Pharmaceuticals 01-Mar-2024 Public Investment 2nd Offering 0000
Gracell 22-Feb-2024 000000000000000000 00000
Icosavax 19-Feb-2024 000000000000000000 00.00
Vellum Biotechnology 31-Dec-2023 000 00 00000000
Impel Pharmaceuticals 19-Dec-2023 0000000000: 000000
PlateletBio 02-Dec-2023 000 00 00000000
RayzeBio 15-Sep-2023 000 00000
Amyris 09-Aug-2023 0000000000: 000000
Tarsus Pharmaceuticals 01-Aug-2023 Public Investment 2nd Offering 00000
IVERIC bio 11-Jul-2023 Merger/Acquisition 00.00
You’re viewing 10 of 180 exits. Get the full list »

Vivo Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Vivo Capital‘s full profile, request access.

Request a free trial

Vivo Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Vivo Capital Management, Team & Partners (62)

Name Title Deals Funds Boards Office
Daisy Xu Managing Director Palo Alto, CA
David Liu Ph.D Managing Director Palo Alto, CA
Hao Dong Managing Director Palo Alto, CA
John Massad Managing Director Palo Alto, CA
Joseph Siletto Managing Director 0 0 0 Palo Alto, CA
You’re viewing 5 of 62 team members. Get the full list »

Vivo Capital Co-Investors (251)

Name With Exits Lead Partner Series Industry
venBio 11 0 Series chart Industry bar
Cormorant Asset Management 0 0 Series chart Industry bar
Novo Holdings 0 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
You’re viewing 5 of 251 co-investors. Get the full list »

Vivo Capital FAQs

  • What is Vivo Capital?

    Founded in 1996, Vivo Capital is a venture capital firm based in Palo Alto, California.

  • When was Vivo Capital founded?

    Vivo Capital was founded in 1996.

  • Who is the founder of Vivo Capital?

    Edgar Engleman MD and Frank Kung Ph.D are the founders of Vivo Capital.

  • Where is Vivo Capital headquartered?

    Vivo Capital is headquartered in Palo Alto, CA.

  • What is Vivo Capital's total asset value?

    Vivo Capital has around 00.00 in total assets under management.

  • How many investments has Vivo Capital made?

    Vivo Capital has made 292 investments.

  • What has Vivo Capital invested in?

    Vivo Capital has made numerous investments in companies like Ajax Therapeutics, Unicycive, and Zenas BioPharma within the Drug Discovery industry.

  • What has Vivo Capital invested in recently?

    Vivo Capital's latest investment was on 13-May-2024 in Ajax Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »